Dr. Labelle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-834-1329
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2006 - 2009
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2003 - 2006
- Medical College of WisconsinClass of 2003
Certifications & Licensure
- IL State Medical License 2012 - 2026
- MA State Medical License 2007 - 2014
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 17 citationsHarnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins.Yu Tian, Matthew V Tirrell, James L LaBelle
Advanced Healthcare Materials. 2022-06-01 - 143 citationsSelf-assembling peptide-based building blocks in medical applications ☆Handan Acar, Samanvaya Srivastava, Eun Ji Chung, Mathew R. Schnorenberg, John C. Barrett
Advanced Drug Delivery Reviews. 2017-02-01 - 18 citationsPolymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular ImmunityLisa R. Volpatti, Rachel P. Wallace, Shijie Cao, Michal M. Raczy, Ruyi Wang
ACS Central Science. 2021-07-21
Press Mentions
- South Side Resident Takes Part in Rare Sickle Cell Disease Clinical Trial Through UChicago MedicineSeptember 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: